ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.

Michael S Toss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.